drugset / Trial / NCT00620776

Combined Treatment for Generalized Anxiety Disorder (GAD)

NCT00620776

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to conduct a preliminary evaluation of the efficacy of combined medication and psychotherapy for generalized anxiety disorder (GAD). The general goals of the current study are to conduct a late stage treatment development study. The goal of this stage of research is to provide a preliminary answer to the question and to gather data to estimate intervention parameters (e.g., effect size, attrition rates, response rates) that would assist in planning further research.

Timeline

Start
2006-10
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Venlafaxine Small molecule 150 mg Oral
Subject Venlafaxine Small molecule 225 mg Oral